IL23A and myeloid sarcoma: In analyses of PBMC from MS patients, Vaknin-Dembinsky et al.showed that monocyte-derived dendritic cells from MS patients secrete higher amounts of IL-23 compared with healthy controls but similar amounts of IL-12 [82].